| Immune evasion in cancer: Mechanistic basis and therapeutic strategies DS Vinay, EP Ryan, G Pawelec, WH Talib, J Stagg, E Elkord, T Lichtor, ... Seminars in cancer biology 35, S185-S198, 2015 | 1641 | 2015 |
| The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies M De Robertis, E Massi, ML Poeta, S Carotti, S Morini, L Cecchetelli, ... Journal of carcinogenesis 10, 2011 | 641 | 2011 |
| Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase–increased expression with reduced muscle damage JM McMahon, E Signori, KE Wells, VM Fazio, DJ Wells Gene therapy 8 (16), 1264-1270, 2001 | 305 | 2001 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 303 | 2015 |
| Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer G Sersa, J Teissie, M Cemazar, E Signori, U Kamensek, G Marshall, ... Cancer Immunology, Immunotherapy 64, 1315-1327, 2015 | 169 | 2015 |
| A somatic mutation in the 5′ UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency E Signori, C Bagni, S Papa, B Primerano, M Rinaldi, F Amaldi, VM Fazio Oncogene 20 (33), 4596-4600, 2001 | 119 | 2001 |
| The Fragile X Protein binds m RNA s involved in cancer progression and modulates metastasis formation R Lucá, M Averna, F Zalfa, M Vecchi, F Bianchi, GL Fata, F Del Nonno, ... EMBO molecular medicine 5 (10), 1523-1536, 2013 | 113 | 2013 |
| Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration P Chiarella, E Massi, M De Robertis, A Sibilio, P Parrella, VM Fazio, ... Expert opinion on biological therapy 8 (11), 1645-1657, 2008 | 91 | 2008 |
| Dysregulation of EGFR pathway in EphA2 cell subpopulation significantly associates with poor prognosis in colorectal cancer M De Robertis, L Loiacono, C Fusilli, ML Poeta, T Mazza, M Sanchez, ... Clinical Cancer Research 23 (1), 159-170, 2017 | 84 | 2017 |
| Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma M Scintu, R Vitale, M Prencipe, AP Gallo, L Bonghi, VM Valori, E Maiello, ... Cancer letters 254 (2), 298-307, 2007 | 68 | 2007 |
| DNA vaccination strategies for anti-tumour effective gene therapy protocols E Signori, S Iurescia, E Massi, D Fioretti, P Chiarella, M De Robertis, ... Cancer immunology, immunotherapy 59, 1583-1591, 2010 | 67 | 2010 |
| Application of electroporation in DNA vaccination protocols P Chiarella, V M Fazio, E Signori Current gene therapy 10 (4), 281-286, 2010 | 59 | 2010 |
| A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients E Signori, E Massi, MG Matera, M Poscente, C Gravina, G Falcone, ... Genes, Chromosomes and Cancer 46 (5), 470-477, 2007 | 59 | 2007 |
| Novel insights into Notum and glypicans regulation in colorectal cancer M De Robertis, M Arigoni, L Loiacono, F Riccardo, RA Calogero, ... Oncotarget 6 (38), 41237, 2015 | 57 | 2015 |
| Alternative BCR/ABL Splice Variants in Philadelphia Chromosome–Positive Leukemias Result in Novel Tumor-Specific Fusion Proteins that May Represent Potential Targets for … G Volpe, A Cignetti, C Panuzzo, M Kuka, K Vitaggio, M Brancaccio, ... Cancer research 67 (11), 5300-5307, 2007 | 56 | 2007 |
| Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells M De Robertis, ML Poeta, E Signori, VM Fazio Seminars in cancer biology 53, 232-247, 2018 | 53 | 2018 |
| Adjuvants in vaccines and for immunisation: current trends P Chiarella, E Massi, M De Robertis, E Signori, VM Fazio Expert opinion on biological therapy 7 (10), 1551-1562, 2007 | 53 | 2007 |
| Tissue damage modeling in gene electrotransfer: the role of pH N Olaiz, E Signori, F Maglietti, A Soba, C Suárez, P Turjanski, S Michinski, ... Bioelectrochemistry 100, 105-111, 2014 | 49 | 2014 |
| EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers M De Robertis, T Mazza, C Fusilli, L Loiacono, ML Poeta, M Sanchez, ... Molecular Cancer 17, 1-9, 2018 | 39 | 2018 |
| Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B … M Rinaldi, F Ria, P Parrella, E Signori, A Serra, SA Ciafre, I Vespignani, ... Cancer Research 61 (4), 1555-1562, 2001 | 39 | 2001 |
